CohBar, Inc. (CWBR) Q1 2022 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Tuhura Biosciences, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.222 -- 00:00:04.845 Good afternoon. My name is John, and I will be your conference operator today. 00:00:04.845 -- 00:00:09.168 At this time, I would like to welcome everyone to COBAR's first quarter 2022 00:00:09.168 -- 00:00:14.071 financial results conference call. All lines have been placed on mute to eliminate background 00:00:14.071 -- 00:00:18.353 noise. If anyone should require operator assistance during the conference, please press 00:00:18.353 -- 00:00:21.255 star zero on your telephone keypad. 00:00:21.255 -- 00:00:25.738 And now I would like to turn the call over to Jeff Beuno, Chief Financial Officer at 00:00:25.738 -- 00:00:28.919 COBAR. Thank you, sir. 00:00:29.226 -- 00:00:34.108 Thank you, John, and thank you, everyone, for joining COBAR's first quarter 2022 00:00:34.108 -- 00:00:38.250 financial results conference call. Joining me on today's call is Dr. 00:00:38.250 -- 00:00:41.531 Joe Surrett, COBAR's chief executive officer, Dr. 00:00:41.531 -- 00:00:45.253 Nick Vlahakis, COBAR's acting chief medical officer, and Dr. 00:00:45.253 -- 00:00:48.915 Kent Grindstaff, senior vice president of research. 00:00:48.915 -- 00:00:53.066 Following our collective remarks, we will conclude with Q&A. 00:00:53.066 -- 00:00:57.248 COBAR's financial results press release was issued earlier today and may be downloaded 00:00:57.248 -- 00:01:00.589 from our website at www.cobar.com. 00:01:01.411 -- 00:01:05.393 Before we begin, I'd like to take a moment to remind listeners that except for statements 00:01:05.393 -- 00:01:10.536 of historical fact, remarks on today's conference call may include forward-looking 00:01:10.536 -- 00:01:13.877 statements within the meaning of the securities laws. 00:01:13.877 -- 00:01:19.320 Forward-looking statements are bas...